These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17432100)

  • 21. Digital vasculitis in systemic lupus erythematosus: a minor manifestation of disease activity?
    Gomes C; Carvalho JF; Borba EF; Borges CT; Vendramini MB; Bueno C; Costa LP; Bonfá E
    Lupus; 2009 Oct; 18(11):990-3. PubMed ID: 19762400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chilblain lupus in an adolescent].
    Brănişteanu DE; Molodoi AD; Stătescu L; Petrescu Z; Vasiluţ D; Anisiei E; Ferariu D; Brănişteanu D
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):646-51. PubMed ID: 20201246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.
    Ramos-Casals M; Nardi N; Lagrutta M; Brito-Zerón P; Bové A; Delgado G; Cervera R; Ingelmo M; Font J
    Medicine (Baltimore); 2006 Mar; 85(2):95-104. PubMed ID: 16609348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasculitis in systemic lupus erythematosus.
    Drenkard C; Villa AR; Reyes E; Abello M; Alarcón-Segovia D
    Lupus; 1997; 6(3):235-42. PubMed ID: 9104729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
    Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
    Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperkeratotic nail discoid lupus erythematosus evolving towards systemic lupus erythematosus: therapeutic difficulties.
    Richert B; André J; Bourguignon R; de la Brassinne M
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):728-30. PubMed ID: 15482310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus.
    Grönhagen CM; Gunnarsson I; Svenungsson E; Nyberg F
    Lupus; 2010 Sep; 19(10):1187-94. PubMed ID: 20501526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous mucinosis associated with lupus erythematosus.
    Fowler JF; Callen JP
    J Rheumatol; 1984 Jun; 11(3):380-3. PubMed ID: 6737378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral lesions in systemic lupus erythematosus. Do ulcerative lesions represent a necrotizing vasculitis?
    Jorizzo JL; Salisbury PL; Rogers RS; Goldsmith SM; Shar GG; Callen JP; Wise CM; Semble EL; White WL
    J Am Acad Dermatol; 1992 Sep; 27(3):389-94. PubMed ID: 1401272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum of cutaneous manifestations in lupus erythematosus--the Italian experience.
    Cardinali C; Caproni M; Bernacchi E; Amato L; Fabbri P
    Lupus; 2000; 9(6):417-23. PubMed ID: 10981645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study.
    Breillat P; Jachiet M; Ditchi Y; Lenormand C; Costedoat-Chalumeau N; Mathian A; Moguelet P; Duriez P; Trendelenburg M; Huynh-Do U; Chizzolini C; Beuvon C; Roy-Peaud F; Bouaziz JD; Barbaud A; Francès C; Mékinian A; Fain O; Amoura Z; Chasset F;
    Rheumatology (Oxford); 2023 Jun; 62(6):2189-2196. PubMed ID: 36190335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement.
    Vitali C; Doria A; Tincani A; Fabbri P; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S17-22. PubMed ID: 9049449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and therapy exploration of active human cytomegalovirus infection in 105 lupus patients.
    Zhang J; Dou Y; Zhong Z; Su J; Xu D; Tang F; Zhang X; Zhao Y; Zeng X; Zhang F; You X
    Lupus; 2014 Aug; 23(9):889-97. PubMed ID: 24836584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
    Fanouriakis A; Mastorodemos V; Pamfil C; Papadaki E; Sidiropoulos P; Plaitakis A; Amoiridis G; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2014 Jun; 43(6):751-8. PubMed ID: 24332007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
    Franceschini F; Calzavara-Pinton P; Quinzanini M; Cavazzana I; Bettoni L; Zane C; Facchetti F; Airò P; McCauliffe DP; Cattaneo R
    Lupus; 1999; 8(3):215-9. PubMed ID: 10342714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.